MYX mayne pharma group limited

Ann: 2022 Half Year Investor Presentation, page-134

  1. 1,471 Posts.
    lightbulb Created with Sketch. 289
    SR / board have clearly failed ordinary retail shareholders sitting in this stock for years watching share value erode away to where it is presently. None of us knows whether things are going to get better or worse for us think depends mainly on Nextstellis referred to as a " game changer" suggesting significant company shift in a positive direction hope not not negative . Board of directors showing little buying interest now Nextstellis been launched , guessing confidence cant be all that great think like us waiting for evidence showing sufficient sales enough to indicate if 20 year Mithra agreement will help us or hurt us (big time) given the all up cost of the product plus increased debt to service . Hope Richards got it right obviously sales / profit will determine that .

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.12
Change
0.050(0.99%)
Mkt cap ! $418.4M
Open High Low Value Volume
$5.13 $5.15 $5.08 $236.3K 46.25K

Buyers (Bids)

No. Vol. Price($)
6 685 $5.12
 

Sellers (Offers)

Price($) Vol. No.
$5.13 69 6
View Market Depth
Last trade - 13.00pm 27/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.